Breakthrough in Cancer Treatment! New Antibody Hv1Lt1 Debuts

[New Antibody Hv1Lt1 Opens New Directions for Cancer Treatment]

The antibody Hv1Lt1 can prevent the activation of the DKK1-CKAP4 pathway in pancreatic cancer and other types of cancer, effectively inhibiting tumor growth and enhancing the efficacy of chemotherapy, offering new hope for treatment.

Key Data:

• Tumor growth was effectively prevented in mouse experiments.
• Enhanced the effects of chemotherapy, further inhibiting cancer cells.
• Provides a new strategy for cancer treatment.

For more details, please visit: https://tinyurl.com/28lx2sy3

Medical Supporter was formerly certified as an international medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).

Figure 1

Figure 2

Figure 3

Figure 4